Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05423249 · ClinicalTrials.gov registry record · NA
Treatment of Non-Anemic Iron Deficiency in Pregnancy
A NA study, sponsored by Stony Brook University.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT05423249 is a NA study that has completed, run by Stony Brook University. The registered enrollment target is 150 participants.
The verdict
NCT05423249, a NA study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
The objective is to investigate the treatment of non-anemic iron deficiency (NAID) and the impact on development of anemia later in pregnancy. Anemia in the third trimester has been identified as a risk factor for maternal and fetal morbidity that might lead to mortality. Due to the high incidence of NAID in pregnancy, there is an opportunity for early screening and treatment to decrease progression to anemia. The primary aim of this study is to establish if treatment of NAID will result in higher third trimester hemoglobin values and decrease incidence of anemia at term.
Interventions
- DRUG Placebo
- DRUG Ferrous sulfate
- DRUG Docusate Sodium
- DRUG Prenatal
- DRUG Ascorbic Acid 500Mg Tab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2022-08-12 |
| Est. Completion | 2024-11-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05423249
The ClinicalTrials.gov registry entry for NCT05423249 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT05423249 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05423249 about?
NCT05423249 is a clinical study titled "Treatment of Non-Anemic Iron Deficiency in Pregnancy". The objective is to investigate the treatment of non-anemic iron deficiency (NAID) and the impact on development of anemia later in pregnancy. Anemia in the third trimester has been identified as a risk factor for maternal and fetal morbidity that might lead to mortality. Due to the high incidence o...
What is the current status of trial NCT05423249?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2022-08-12. Estimated completion is 2024-11-15.
What interventions are being tested in trial NCT05423249?
The interventions under investigation include: Placebo (DRUG), Ferrous sulfate (DRUG), Docusate Sodium (DRUG), Prenatal (DRUG), Ascorbic Acid 500Mg Tab (DRUG).
Who is sponsoring clinical trial NCT05423249?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.